Vantage Oncology Finds $22M

El Segundo-based Vantage Oncology announced yesterday that it has raised $22M in a Series C funding for expanding its cancer treatment centers. Vantage operates radiation oncology centers nationwide, and will use the funding to acquire and development more treatment facilities. The new round of funding was led by New Enterprise Associates and Conning Capital Partners, existing investors in the company. Other existing investors Versant Ventures and Salix Ventures also participated. More information »